Newamsterdam Pharma Company Nv (NAMS)

Panoramica Notizia Cronologia dei prezzi Financials Perché NAMS Giù? Forum Previsione

Newamsterdam Pharma Company Nv Azioni (NAMS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31
Durata del periodo	3 mesi
Revenues
Operating Expenses
Benefits Costs and Expenses
Costs And Expenses
Operating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Diluted Average Shares
Basic Earnings Per Share
Diluted Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic

BMRN

$70.49

2.14%

SMMT

$18.50

2.83%

UTHR

$304.42

4.23%

RPRX

$32.46

0.89%

BNTX

$98.39

6.61%

ONC

$245.71

1.26%